Register to join us for our webinar on September 19th @ 4pm BST!

With over 12 different types of human papilloma virus (HPV) that can cause cancer, it is the leading cause of cervical cancer in women. The HPV/Pap smear co-test has improved the accuracy of cervical cancer screening; however the test has several limitations. Recent advancements in molecular diagnostics have led to the development of genotype-specific HPV tests that accurately detect and differentiate HPV strains, including high-risk oncogenic types such as HPV-16 and HPV-18.

In this webinar you will:

• Learn about HPV type-specific testing
• Explore the recent trends in HPV diagnostics
• Discover urine-specific genotyping chemistry, which can provide a non-invasive, sensitive method for HPV detection

Date/Time: Thu, Sep 19, 2024 11:00 AM – 12:00 PM EDT

Speaker: Steve Hawkins, Ph.D., Meridian Life Science Molecular Product Manager

With the global increase of sexually transmitted infections (STIs), the need for accessible and accurate STI diagnostic solutions has never been more critical. Traditional testing methods are hindered by several barriers, including limited accessibility and STI-related stigma. This is further compounded by the challenge of asymptomatic infections, which deter initial testing. However, the unprecedented adoption of at-home testing and telemedicine that developed during the COVID-19 pandemic has facilitated the expansion of at-home and self-collection assays for several diseases, such as STIs. Join us as we delve into the changing landscape of STI testing, highlighting the new developments in at-home testing and the molecular and immunoassay reagent solutions for developing new STI assays.

IN THIS WEBINAR, YOU WILL LEARN ABOUT:

• What has changed in STI testing in the post-COVID market and the key differences between home-testing vs. self-collection assays
• Innovative molecular chemistries that enable sensitive direct detection using crude samples
• High-performing immuno-reagents ideal for rapid lateral flow tests
• The future direction of STI screening: trends and growth predictions

Speakers:

Steve Hawkins, Ph.D., Merdian Life Science Molecular Product Manager

Ryan Hughes, Ph.D, Merdian Life Science Immuno Product Manager

Avoiding immunoassay interference requires blockers to be included in every immunoassay. Historically, animal-based interference blockers have been used to improve assay accuracy; however, they are susceptible to cross-reactivity with assay reagents, lot-to-lot variability, and supply shortages – as seen during the COVID-19 pandemic. Meridian’s new animal-free commercial blockers, K-BlockTM and Mouse-FREE IgG, are the next-generation solution for blocking HAMA/RF/HA that overcomes the ethical concerns and supply problems in using animal-derived blockers.

In this webinar you will learn the advantages of using animal-free immunoassay blockers and their performance.

Speakers:

Ryan Hughes Ph.D, (Life Science Immunology Product Manager, Meridian Bioscience)

Tatiana Chirkova, Ph.D, (Upstream Process Development Scientist, Meridian Bioscience)